资讯
The Pulmonary Hypertension Association has launched a new certificate program for advanced practice providers and allied health professionals. The Pulmonary Hypertension Certificate program is ...
Background: The use of appetite suppressants in Europe has been associated with the development of primary pulmonary hypertension (PPH). Recently, fenfluramine appetite suppressants became widely ...
Two forensic pathologists from the United States (US) are due in Guyana to conduct the autopsy of the body of 11-year-old Adrianna Younge, which was found in a pool at Double Day Hotel, Tuschen, East ...
1 天
MedPage Today on MSNRace-Neutral Spirometry Equations Catch Missed Lung Abnormalities in Black AdultsThose reclassified cases appeared to have lung pathology missed by the prior equations, as the newly abnormal group had ...
Earlier studies often prioritized one scale at the expense of the other and, because this, missed critical connections. In pulmonary hypertension, however, this partnership turns lethal. PAAFs start ...
Pulmonary arterial hypertension (PAH) is a type of pulmonary hypertension that causes high blood pressure in the small arteries of the lungs. It is a serious condition that can impair blood flow ...
"Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis" has shed light on the potential of pulmonary artery denervation (PADN) as an innovative intervention for ...
The importance of hypertension of the pulmonary circulation in the natural history of mitral stenosis has been appreciated for many years. Many of the classic signs of this type of cardiac disease ...
Weak: only small or nonrandomized trials available; Unknown: not enough data to determine benefit. ERA: Endothelin receptor antagonist; PDE5: Phosphodiesterase type 5; PH: Pulmonary hypertension.
"Pulmonary hypertension usually affects people aged 30 to 60. Its early signs and symptoms can mimic those of various other medical conditions, making early detection challenging," explains Dr Garde.
Background Pulmonary hypertension (PHT) lacks community prevalence and outcome data. Objective To characterise minimum ‘indicative’ prevalences and mortality data for all forms of PHT in a selected ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果